A cluster-randomised, non-inferiority trial of the impact of a two-dose compared to three-dose schedule of pneumococcal conjugate vaccination in rural Gambia: the PVS trial.

MLA

Mackenzie, Grant A., et al. “A Cluster-Randomised, Non-Inferiority Trial of the Impact of a Two-Dose Compared to Three-Dose Schedule of Pneumococcal Conjugate Vaccination in Rural Gambia: The PVS Trial.” Trials, vol. 23, no. 1, Jan. 2022, pp. 1–23. EBSCOhost, https://doi.org/10.1186/s13063-021-05964-5.

APA

Mackenzie, G. A., Osei, I., Salaudeen, R., Hossain, I., Young, B., Secka, O., D’Alessandro, U., Palmu, A. A., Jokinen, J., Hinds, J., Flasche, S., Mulholland, K., Nguyen, C., & Greenwood, B. (2022). A cluster-randomised, non-inferiority trial of the impact of a two-dose compared to three-dose schedule of pneumococcal conjugate vaccination in rural Gambia: the PVS trial. Trials, 23(1), 1–23. https://doi.org/10.1186/s13063-021-05964-5

Chicago

Mackenzie, Grant A., Isaac Osei, Rasheed Salaudeen, Ilias Hossain, Benjamin Young, Ousman Secka, Umberto D’Alessandro, et al. 2022. “A Cluster-Randomised, Non-Inferiority Trial of the Impact of a Two-Dose Compared to Three-Dose Schedule of Pneumococcal Conjugate Vaccination in Rural Gambia: The PVS Trial.” Trials 23 (1): 1–23. doi:10.1186/s13063-021-05964-5.